Susquehanna International Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
256,966
+52,765
| +26% | +$921K | ﹤0.01% | 1416 |
|
|
2025
Q1 | $2.57M | Buy |
204,201
+32,816
| +19% | +$413K | ﹤0.01% | 1960 |
|
|
2024
Q4 | $1.81M | Buy |
171,385
+24,094
| +16% | +$254K | ﹤0.01% | 2120 |
|
|
2024
Q3 | $2.14M | Buy |
147,291
+121,790
| +478% | +$1.77M | ﹤0.01% | 1804 |
|
|
2024
Q2 | $217K | Sell |
25,501
-55,344
| -68% | -$471K | ﹤0.01% | 4635 |
|
|
2024
Q1 | $826K | Sell |
80,845
-172,571
| -68% | -$1.76M | ﹤0.01% | 2884 |
|
|
2023
Q4 | $1.39M | Buy |
253,416
+77,873
| +44% | +$427K | ﹤0.01% | 2405 |
|
|
2023
Q3 | $664K | Buy |
175,543
+24,183
| +16% | +$91.4K | ﹤0.01% | 3044 |
|
|
2023
Q2 | $1.01M | Sell |
151,360
-161,594
| -52% | -$1.08M | ﹤0.01% | 2699 |
|
|
2023
Q1 | $2.04M | Buy |
312,954
+267,008
| +581% | +$1.74M | ﹤0.01% | 1946 |
|
|
2022
Q4 | $392K | Buy |
+45,946
| New | +$392K | ﹤0.01% | 3535 |
|
|
2022
Q3 | – | Sell |
-151,582
| Closed | -$643K | – | 6850 |
|
|
2022
Q2 | $643K | Buy |
+151,582
| New | +$643K | ﹤0.01% | 3025 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6467 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6409 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6028 |
|